Do you recall the Canadian company which was trying to manufacture spider silk transgenically? They had a license from GTC and I believe that that is the license now held by Pharmathene. There are all sorts of potential industrial applications but the problem, I'm told, was they could not get the spider silk to spin.
My 'dumb idea' remains with CABG and a label expansion for Atryn. I'm hoping that Ovation will be able to move quickly, like they did in partnering with GTC, and a clinical trial design for heparin resistance in CABG can be completed this year and the trial started in the first part of 2009 and completed in 2009. In case anyone is wondering I haven't even been in a Dutch 'coffee house' today. Yet.